|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00996450 |
|
Date of registration:
|
15/10/2009 |
|
Primary sponsor: |
|
|
Public title:
|
Educational Follow-up in a Cohort of Children at the Royal Marsden Hospital (RMH)
|
|
Scientific title:
|
Educational Follow-up in a Cohort of Children at the Royal Marsden Hospital, Following the Treatment of a Brain Tumour |
|
Date of first enrolment:
|
June 2008 |
|
Target sample size:
|
110 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT00996450 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Family-Based, Time Perspective: Retrospective
|
|
|
Countries of recruitment
|
|
United Kingdom
| | | | | | | |
|
Contacts
|
|
Name:
|
Dr Darren Hargrave |
|
Address:
|
|
|
Telephone:
|
0208642 6011 |
|
Email:
|
darren.hargrave@rmh.nhs.uk |
|
Affiliation:
|
|
|
|
Name:
|
Dr Darren Hargrave |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Royal Marsden NHS Foundation Trust |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- patients/parental consent for RMH accessing educational information from them and
their school
- patients with a primary brain tumour
Exclusion Criteria:
- children with secondary brain tumours
- children who have had treatment for a relapse of primary brain tumour
Age minimum:
4 Years
Age maximum:
18 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Brain Tumour
|
|
Secondary Outcome(s)
|
|
To compare educational achievements of children of different tumour types following treatment.
[Time Frame: No]
|
|
To document if there are any differences in educational achievements depending on the age at diagnosis of the brain tumour.
[Time Frame: No]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|